Adenovirus (Ad) vector vaccines have been frequently reported in recent years as the main force against COVID-19. In fact, Ad vaccines have a wide range of applications, and also play an importantRead More…
Nature: Custom New Antigen Tumor Vaccine Research Progress and Challenges
Vaccines have traditionally been used to prevent infectious diseases. However, the ability of this drug to induce and amplify antigen-specific immune responses has long been considered a potentially valuable tool for cancerRead More…
Sci Immunol: Why Vaccines Against Malaria Quickly Lose Their Protective Effects
In a study published in the international journal Science Immunology titled “Clonal evolution and TCR specificity of the human TFH cell response to Plasmodium falciparum CSP”, scientists from the German Cancer ResearchRead More…
Nature: Influenza Vaccine Can Reduce Severe Illness From COVID-19 by 90%!
Recently, the research team of Doha Cornell Medical Center published the research results entitled “Effectiveness of influenza vaccination against SARS-CoV-2 infection among healthcare workers in Qatar” on the medRxiv. The study foundRead More…
News and Facts About Monkeypox Virus
Monkeypox is a rare viral infectious disease similar to human smallpox caused by monkeypox virus. It is also a zoonosis. Mainly found in the rainforest regions of central and western Africa. ItRead More…
Spherical Nucleic Acid Vaccine—Amazing Vaccine Candidate
Under the background of the global COVID-19 pandemic, amazing progress has been made in the field of vaccine research and development, and there are more and more different types of vaccines basedRead More…
Cell Rep: mRNA Vaccine Technology May Help to Develop New HIV Vaccines
Using nucleoside modified mRNAs in lipid nanoparticles (mRNA-LNP) as a vaccine for COVID-19 may successfully predict a new era of vaccine development. For HIV-1, polyvalent enveloped trimer protein nanoparticles may be usedRead More…
Respiratory Syncytial Virus (RSV) Vaccine: Breakthrough Therapy RSVpreF Approved by FDA
Recently, the US Food and Drug Administration (FDA) has granted respiratory syncytial virus (RSV) bivalent pre-fused F subunit vaccine (RSVpreF) breakthrough therapy recognition (BTD), which is an active immunization for the pregnantRead More…
Nat Commun: Natural env Trimer Produces Tier-2 Neutralizing Antibodies Against HIV In Vivo
Nearly 40 years after the discovery of HIV, it has killed 36.3 million people, but so far there is still no effective vaccine available. In a new study, however, researchers from theRead More…
New strategy for vaccine development! Memory helper T cells perpetuate memory B cells that resist chronic viral infection
Viruses such as HIV or hepatitis C virus (HCV) can destroy the immune system. So far, one way to develop vaccines against these chronic infections is to target memory B cells, aRead More…
